• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

Stock News

New Year, No Fear | Seeking Alpha

January 6, 2023 admin 0

Talaj/iStock via Getty Images This will be a short one. New years are a time for reflection, especially those that follow tough years filled with challenging lessons. When we learn those lessons (or do our […]

Stock News

Catalent: Starting Valuations, ROIC Supportive, Rate Buy (CTLT)

January 6, 2023 admin 0

Pgiam/iStock via Getty Images Investment Thesis Summary There are numerous selective opportunities on sale within the broad healthcare segment at present. Starting valuations in many names are now far more respectable, and various short-term volatility […]

Stock News

Wall Street Breakfast January 6: Nonfarm Payrolls Provide

January 6, 2023 admin 0

This article was written by Subscribe Wall Street Breakfast, Seeking Alpha’s flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day’s key financial news. It’s designed for […]

Posts navigation

« 1 … 4,114 4,115 4,116 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • As bear market looms, battered Wall St seeks elusive ‘Fed put’ By Reuters
    May 20, 2022 0
  • Marketplace suspends most NFT sales, citing ‘rampant’ fakes and plagiarism By Reuters
    February 12, 2022 0
  • Asia shares slip as U.S. jobs stunner hammers bonds By Reuters
    February 7, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.